Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
about
Beyond CA125: the coming of age of ovarian cancer biomarkersGlycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical reviewChange in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.Variations in the metabolome in response to disease activity of rheumatoid arthritis.Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritisCharacterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis.Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.Identification of novel plasma glycosylation-associated markers of aging.Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types.Developments in the scientific understanding of rheumatoid arthritis.IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.Clinical aspects of glycoprotein biosynthesis.Effect of circulating immune complexes on the binding of rheumatoid factor to histones.Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis.Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.Changes in N-glycans of IgG4 and its relationship with the existence of hypocomplementemia and individual organ involvement in patients with IgG4-related disease.
P2860
Q24651567-75FB6457-E602-4202-812E-F3F4FDD32494Q26782025-B0E0E51E-175D-46F3-A020-A831A2ABDC8AQ34772586-FD36BE0D-5B81-4B48-9B02-C21858DC3026Q35014345-A86ECB32-0A3A-4806-ACBA-53771A7E4BE7Q35689463-774BE5FC-FEAE-4C6E-A0D6-759D437E38F5Q36109439-D6BBAD97-777A-4CE6-9FD3-A88053331314Q36245665-1FC14860-8416-4021-9B4B-1E8312F35772Q36342795-B2B9D83F-5D3C-40DB-99B1-E8673CE39ECAQ36363690-17AE60ED-CA00-40CD-9BAD-D638960A545FQ36768842-4509FDA7-17A2-4A88-A145-51A95FBF1069Q36946538-73787B0B-488A-45B4-B30F-91E0323FA946Q37151471-BA21903F-FB42-4C69-B9A8-71B0AB4DFF30Q37454068-18D9709F-3464-4536-9FBA-DBB5AFC85328Q38115691-4A7E3BC0-2497-465B-AC3F-C7DAB23ECC14Q40841843-D05FE64D-A134-44FA-9D2F-1788F660D92DQ41866152-2CD407E0-A9A9-4804-A22A-0E9369495B15Q42161016-83908AB8-6228-4E65-AE32-3C7AB1E6B746Q52807572-DB1B9405-121E-4886-B902-356DF767721AQ55510375-79F4EB90-01FF-4DE5-A4CF-E77178B03086
P2860
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@ast
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@en
type
label
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@ast
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@en
prefLabel
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@ast
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@en
P2093
P2860
P356
P1476
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease
@en
P2093
P2860
P304
P356
10.1172/JCI115643
P407
P577
1992-03-01T00:00:00Z